Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hormonal treatment comparison for uterine endometriosis (adenomyosis)
RBR-722dg2yPhase 3Not yet recruiting
- Sponsor
- Universidade Estadual de Campinas
- Start
- Feb 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dienogest, etonogestrel and avatrombopag in adenomyosis, sponsored by Universidade Estadual de Campinas. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
dienogestetonogestrelavatrombopag
03
Conditions
adenomyosis
Beyond the preview
Go deeper on RBR-722dg2y.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-722dg2y.